Samra Turajlic

Title: Samra Turajlic: Innovator in Personalized ctDNA Disease Monitoring

Introduction

Samra Turajlic is a prominent inventor based in London, GB. She has made significant contributions to the field of genetic research, particularly in the area of personalized disease monitoring. Her innovative approach focuses on utilizing representative DNA sequencing to enhance disease detection and monitoring.

Latest Patents

Turajlic holds a patent for a method titled "Personalized ctDNA disease monitoring via representative DNA sequencing." This patent describes a method of deriving a plurality of genetic variants from a homogenized input sample. The process involves homogenizing one or more input samples to provide a homogenized sample, preparing genomic material isolated from the homogenized input sample for sequencing, and identifying the plurality of genetic variants within sequencing data derived after sequencing the prepared genomic material. She has 1 patent to her name.

Career Highlights

Throughout her career, Samra Turajlic has worked with notable organizations, including Ventana Medical Systems, Inc. and The Francis Crick Institute Limited. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

One of her notable coworkers is Kevin Richard Litchfield, with whom she has collaborated on various projects. Their partnership has further advanced the research in genetic monitoring and disease detection.

Conclusion

Samra Turajlic's innovative work in personalized ctDNA disease monitoring exemplifies her commitment to advancing genetic research. Her contributions are paving the way for improved disease detection methods, ultimately benefiting patients and the medical community.